CIK 0001380106 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RAPID MICRO BIOSYSTEMS, INC.
Sign in to watch- Ticker
- RPID
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208121647
- Phone
- 978-349-3200
- Business address
- 25 HARTWELL AVENUE, LEXINGTON, MA, 02421
- Former names
- RAPID MICRO BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | WIRTJES SEAN M CHIEF FINANCIAL OFFICER | Grant or award · Series B Warrant (right to buy) | +12,787 | 12,787 | ||
| 2026-05-21 | Bika Dafni Director | Grant or award | +19,300 | 19,300 | ||
| 2026-05-21 | Bika Dafni Director | Grant or award · Stock Option (Right to Buy) | +38,700 | 38,700 | ||
| 2026-05-21 | LOWENSTEIN INESE Director | Grant or award | +19,300 | 57,900 | ||
| 2026-05-21 | LOWENSTEIN INESE Director | Grant or award · Stock Option (Right to Buy) | +38,700 | 38,700 | ||
| 2026-05-21 | PEI MELINDA LITHERLAND Director | Grant or award | +19,300 | 87,900 | ||
| 2026-05-21 | PEI MELINDA LITHERLAND Director | Grant or award · Stock Option (Right to Buy) | +38,700 | 38,700 | ||
| 2026-05-21 | Kollender Richard S Director | Grant or award | +19,300 | 130,318 | ||
| 2026-05-21 | Kollender Richard S Director | Grant or award · Stock Option (Right to Buy) | +38,700 | 38,700 | ||
| 2026-05-21 | Malloy Kirk Director | Grant or award | +19,300 | 47,900 | ||
| 2026-05-21 | Malloy Kirk Director | Grant or award · Stock Option (Right to Buy) | +38,700 | 38,700 | ||
| 2026-05-20 | Bain Capital Life Sciences Investors, LLC 10% owner | Purchase · Pre-Funded Warrant (right to buy) | +1,463,000 | 1,463,000 | ||
| 2026-05-20 | Bain Capital Life Sciences Investors, LLC 10% owner | Purchase · Series A Warrant (right to buy) | +1,463,000 | 1,463,000 | ||
| 2026-05-20 | Bain Capital Life Sciences Investors, LLC 10% owner | Purchase · Series B Warrant (right to buy) | +1,463,000 | 1,463,000 | ||
| 2026-03-11 | Wilson John J. Addington CHIEF OPERATING OFFICER | Sale | −9,603 | $4.32 | $41K | 316,762 |
| 2026-03-11 | WIRTJES SEAN M CHIEF FINANCIAL OFFICER | Sale | −7,480 | $4.32 | $32K | 556,194 |
| 2026-03-10 | Spignesi Robert G. Jr. PRESIDENT AND CEO | Sale | −17,922 | $4.11 | $74K | 1,169,848 |
| 2026-02-27 | RICCIARDI NATALE S Director | Option exercise | +842 | $0.75 | $632 | 29,442 |
| 2026-02-27 | RICCIARDI NATALE S Director | Option exercise · Stock Option (Right to Buy) | −842 | $0.75 | $632 | 0 |
| 2026-02-20 | Wilson John J. Addington CHIEF OPERATING OFFICER | Sale | −5,403 | $3.92 | $21K | 326,365 |
Page 2 of 9 · 178 trades